(Total Views: 231)
Posted On: 10/11/2019 1:32:40 PM
Post# of 149255
I'm not holding my breath, but it could happen. They may have multiple emergency patients injected already and if emergency or trial patients results are positive, I would think enrollment could happen pretty quick. From today, there enough days to get 4 cycles. I don't think we will know before 1 January, but IMO it wouldn't be too much longer.
How many people, will they only release trial patient's CTC readings, how many and 21-days cycles are needed to provide public initial CTC results? IMO, positive results from the emergency patient/s will be more significant than the trial readings due to the later stage, exhausted treatments and likely overall worse condition. If leronlimab can be effective that late (2 of 4 mice survived) may not sound great on the surface, but 50% is better than pretty much any other toxic cancer drug currently out there. I would think if it halfway works with these patients, then trial results will be even stronger.
How many people, will they only release trial patient's CTC readings, how many and 21-days cycles are needed to provide public initial CTC results? IMO, positive results from the emergency patient/s will be more significant than the trial readings due to the later stage, exhausted treatments and likely overall worse condition. If leronlimab can be effective that late (2 of 4 mice survived) may not sound great on the surface, but 50% is better than pretty much any other toxic cancer drug currently out there. I would think if it halfway works with these patients, then trial results will be even stronger.
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
Scroll down for more posts ▼